Literature DB >> 27362918

Cell Polarity Proteins in Breast Cancer Progression.

Carlis Rejon1, Maia Al-Masri1, Luke McCaffrey1.   

Abstract

Breast cancer, one of the leading causes of cancer related death in women worldwide, is a heterogeneous disease with diverse subtypes that have different properties and prognoses. The developing mammary gland is a highly proliferative and invasive tissue, and some of the developmental programs may be aberrantly activated to promote breast cancer progression. In the breast, luminal epithelial cells exhibit apical-basal polarity, and the failure to maintain this organizational structure, due to disruption of polarity complexes, is implicated in promoting hyperplasia and tumors. Therefore, understanding the mechanisms underlying loss of polarity will contribute to our knowledge of the early stages leading to the pathogenesis of the disease. In this review, we will discuss recent findings that support the idea that loss of apical-basal cell polarity is a crucial step in the acquisition of the malignant phenotype. Oncogene induced loss of tissue organization shares a conserved cellular mechanism with developmental process, we will further describe the role of the individual polarity complexes, the Par, Crumbs, and Scribble, to couple cell division orientation and cell growth. We will examine symmetric or asymmetric cell divisions in mammary stem cell and their contribution to the development of breast cancer subtypes and cancer stem cells. Finally, we will highlight some of the recent advances in our understanding of the molecular mechanisms by which changes in epithelial polarity programs promote invasion and metastasis through single cell and collective cell modes. J. Cell. Biochem. 117: 2215-2223, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  BREAST CANCER; CELL POLARITY; INVASION; METASTASIS; PAR COMPLEX; SCRIB

Mesh:

Substances:

Year:  2016        PMID: 27362918     DOI: 10.1002/jcb.25553

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  A multivariate statistical test for differential expression analysis.

Authors:  Michele Tumminello; Giorgio Bertolazzi; Gianluca Sottile; Nicolina Sciaraffa; Walter Arancio; Claudia Coronnello
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

2.  PtdIns(3,4,5)P3-dependent Rac exchanger 1 (P-Rex1) promotes mammary tumor initiation and metastasis.

Authors:  Nuthasuda Srijakotre; Heng-Jia Liu; Max Nobis; Joey Man; Hon Yan Kelvin Yip; Antonella Papa; Helen E Abud; Kurt I Anderson; Heidi C E Welch; Tony Tiganis; Paul Timpson; Catriona A McLean; Lisa M Ooms; Christina A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-23       Impact factor: 11.205

Review 3.  Therapy-induced chemoexosomes: Sinister small extracellular vesicles that support tumor survival and progression.

Authors:  Shyam K Bandari; Kaushlendra Tripathi; Sunil Rangarajan; Ralph D Sanderson
Journal:  Cancer Lett       Date:  2020-08-26       Impact factor: 8.679

Review 4.  Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.

Authors:  Katrina M Piemonte; Lindsey J Anstine; Ruth A Keri
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

5.  A Machine Learning Assisted, Label-free, Non-invasive Approach for Somatic Reprogramming in Induced Pluripotent Stem Cell Colony Formation Detection and Prediction.

Authors:  Ke Fan; Sheng Zhang; Ying Zhang; Jun Lu; Mike Holcombe; Xiao Zhang
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

6.  High expression of DLG3 is associated with decreased survival from breast cancer.

Authors:  Jie Liu; Pingping Li; Ruiqi Wang; Juan Li; Miao Zhang; Zhangjun Song; Peijun Liu
Journal:  Clin Exp Pharmacol Physiol       Date:  2019-07-31       Impact factor: 2.557

7.  Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.

Authors:  Mei Wu; Qi Sun; Chao-Hua Mo; Jin-Shu Pang; Jia-Yin Hou; Ling-Ling Pang; Hui-Ping Lu; Yi-Wu Dang; Su-Jie Fang; Deng Tang; Gang Chen; Zhen-Bo Feng
Journal:  Oncol Rep       Date:  2019-05-03       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.